Supurva Healthcare Group, Inc.
SPRV · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $516 | $559 | $872 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $516 | $559 | $872 | $0 |
| Operating Income | -$516 | -$559 | -$872 | $0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$185 | -$124 | -$28 | -$34 |
| Pre-Tax Income | -$700 | -$684 | -$900 | -$34 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$700 | -$684 | -$900 | -$34 |
| % Margin | – | – | – | – |
| EPS | -0 | -0.001 | -0.002 | -0.003 |
| % Growth | 50% | 71.4% | 19.2% | – |
| EPS Diluted | -0 | -0.001 | -0.002 | -0.003 |
| Weighted Avg Shares Out | 2,475,144 | 1,162,129 | 428,530 | 13,074 |
| Weighted Avg Shares Out Dil | 2,475,144 | 1,162,129 | 428,530 | 13,074 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $185 | $124 | $28 | $34 |
| Depreciation & Amortization | $168 | $228 | $237 | $206 |
| EBITDA | -$516 | -$559 | -$872 | $206 |
| % Margin | – | – | – | – |